Seth Medipharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 9.30 M
About Seth Medipharma
Seth Medipharma Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 2010 and has a history of 14 years and eight months. Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹9.30 M.
Sanjay Seth, Saroj Ram, and Anita Giri serve as directors at the Company.
Company Details
-
Location
Haridwar, Uttarakhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33111UR2010PTC033168
-
Company No.
033168
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 May 2010
-
Date of AGM
30 Sep 2014
-
Date of Balance Sheet
31 Mar 2014
-
Listing Status
Unlisted
-
ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Seth Medipharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Seth
|
Director | 20-May-2010 | Current |
|
Saroj Ram
|
Director | 20-May-2010 | Current |
|
Anita Giri
|
Director | 20-May-2013 | Current |
Financial Performance of Seth Medipharma.
Enhance accessibility to Seth Medipharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Seth Medipharma?
Unlock access to Seth Medipharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.30 M
₹0
Charges Breakdown by Lending Institutions
- Panjab National Bank : 0.63 Cr
- Punjab National Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 2011 | Panjab National Bank | ₹6.30 M | Open |
| 07 Jan 2011 | Punjab National Bank | ₹3.00 M | Open |
How Many Employees Work at Seth Medipharma?
Unlock and access historical data on people associated with Seth Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Seth Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Seth Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.